UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial

Trials, 2014-08, Vol.15 (1), p.317-317, Article 317

2014

Volltextzugriff (PDF)

Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer

Anticancer research, 2008-09, Vol.28 (5B), p.2851-2857

2008

Volltextzugriff (PDF)

Correction: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial (vol 15, 317, 2014)

Trials, 2015, Vol.16 (334)

2015

Volltextzugriff (PDF)

W‐7, a calmodulin inhibitor, potentiates dacarbazine cytotoxicity in human neoplastic cells

International journal of cancer, 1987-05, Vol.39 (5), p.638-642

1987

Volltextzugriff (PDF)

Erratum to: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial

Trials, 2015-08, Vol.16 (1), p.334-334, Article 334

2015

Volltextzugriff (PDF)

Interaction between 5-fluorouracil and DNA of human colon adenocarcinoma

Cancer research (Chicago, Ill.), 1984-08, Vol.44 (8), p.3414-3418

1984

Volltextzugriff (PDF)

5-Fluoropyrimidine-induced DNA damage in human colon adenocarcinoma and its augmentation by the nucleoside transport inhibitor dipyridamole

Cancer research (Chicago, Ill.), 1989-03, Vol.49 (5), p.1085-1089

1989

Volltextzugriff (PDF)

Increased levels of DNA lesions induced by leucovorin-5-fluoropyrimidine in human colon adenocarcinoma

Cancer research (Chicago, Ill.), 1988-08, Vol.48 (15), p.4153-4157

1988

Volltextzugriff (PDF)

Prognostic value of amplification of c-erb-B2 in bladder carcinoma

Clinical cancer research, 1995-10, Vol.1 (10), p.1189-1194

1995

Volltextzugriff (PDF)

Altered formation of DNA in human cells treated with inhibitors of DNA topoisomerase II (etoposide and teniposide)

Cancer research (Chicago, Ill.), 1989-11, Vol.49 (22), p.6202-6207

1989

Volltextzugriff (PDF)

Reduced DNA damage induced in human melanoma cells by dacarbazine in the presence of deoxyribonucleosides

Cancer research (Chicago, Ill.), 1989-06, Vol.49 (11), p.2921-2924

1989

Volltextzugriff (PDF)

Reduced repair of X-ray-induced DNA lesions in cells without functioning DNA polymerase alpha

Radiation research, 1985-04, Vol.102 (1), p.71

1985

Volltextzugriff (PDF)

Stability of DNA in mammalian cells irradiated with near-uv light (uv-a)

Radiation research, 1984-09, Vol.99 (3), p.659

Lönn, U

1984

Volltextzugriff (PDF)

Prognostic value of erb‐B2 and myc amplification in breast cancer imprints

Cancer, 1995-06, Vol.75 (11), p.2681-2687

1995

Volltextzugriff (PDF)

Higher frequency of gene amplification in breast cancer patients who received adjuvant chemotherapy

Cancer, 1996-01, Vol.77 (1), p.107-112

1996

Volltextzugriff (PDF)

Intratumoral heterogeneity for amplified genes in human breast carcinoma

International journal of cancer, 1994-07, Vol.58 (1), p.40-45

1994

Volltextzugriff (PDF)

Refutation of investigation commissioned by Karolinska Institute

The Lancet (British edition), 1998-01, Vol.351 (9099), p.375-375

Lonn, U

1998

Volltextzugriff (PDF)

Gene amplification detected in carcinoma cells from human urinary bladder washings by the polymerase chain reaction method

Cancer, 1993-06, Vol.71 (11), p.3605-3610

1993

Volltextzugriff (PDF)

Prognostic significance of c-erb-B2 amplification in fine-needle biopsies of breast cancer patients not operated at diagnosis

Breast cancer research and treatment, 1996-01, Vol.39 (2), p.213-220

1996

Volltextzugriff (PDF)

Appearance and detection of multiple copies of the mdr‐1 gene in clinical samples of mammary carcinoma

International journal of cancer, 1992-07, Vol.51 (5), p.682-686

1992

Volltextzugriff (PDF)

Prognostic value oferb-B2 andmyc amplification in breast cancer imprints

Cancer, 1995-06, Vol.75 (11), p.2681-2687

1995

Volltextzugriff (PDF)

Formation of 10-kilobase DNA replication intermediates

Biochemical Society transactions, 1983-08, Vol.11 (4), p.361-361

LÖNN, ULF

1983

Volltextzugriff (PDF)

Breast cancer : prognostic significance of c-erb-B2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features

Breast cancer research and treatment, 1994, Vol.29 (3), p.237-245

1994

Volltextzugriff (PDF)

Appearance of amplified thymidylate synthase or dihydrofolate reductase genes in stage‐IV breast‐cancer patients receiving endocrine treatment

International journal of cancer, 1993-05, Vol.54 (2), p.237-242

1993

Volltextzugriff (PDF)

C‐ERB‐B2/INT‐2 amplification appears faster in breast‐cancer patients receiving second‐line endocrine treatment

International journal of cancer, 1996-08, Vol.69 (4), p.273-277

1996

Volltextzugriff (PDF)

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(84)

Publikationsform

Artikel
(92)

Sprache

Englisch
(92)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial

Multicentre Phase II Trial of Paclitaxel and Carboplatin with Concurrent Radiotherapy in Locally Advanced Non-small Cell Lung Cancer

Correction: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial (vol 15, 317, 2014)

W‐7, a calmodulin inhibitor, potentiates dacarbazine cytotoxicity in human neoplastic cells

Erratum to: Isolated hepatic perfusion as a treatment for uveal melanoma liver metastases (the SCANDIUM trial): study protocol for a randomized controlled trial

Interaction between 5-fluorouracil and DNA of human colon adenocarcinoma

5-Fluoropyrimidine-induced DNA damage in human colon adenocarcinoma and its augmentation by the nucleoside transport inhibitor dipyridamole

Increased levels of DNA lesions induced by leucovorin-5-fluoropyrimidine in human colon adenocarcinoma

Prognostic value of amplification of c-erb-B2 in bladder carcinoma

Altered formation of DNA in human cells treated with inhibitors of DNA topoisomerase II (etoposide and teniposide)

Reduced DNA damage induced in human melanoma cells by dacarbazine in the presence of deoxyribonucleosides

Reduced repair of X-ray-induced DNA lesions in cells without functioning DNA polymerase alpha

Stability of DNA in mammalian cells irradiated with near-uv light (uv-a)

Prognostic value of erb‐B2 and myc amplification in breast cancer imprints

Higher frequency of gene amplification in breast cancer patients who received adjuvant chemotherapy

Intratumoral heterogeneity for amplified genes in human breast carcinoma

Refutation of investigation commissioned by Karolinska Institute

Gene amplification detected in carcinoma cells from human urinary bladder washings by the polymerase chain reaction method

Prognostic significance of c-erb-B2 amplification in fine-needle biopsies of breast cancer patients not operated at diagnosis

Appearance and detection of multiple copies of the mdr‐1 gene in clinical samples of mammary carcinoma

Prognostic value oferb-B2 andmyc amplification in breast cancer imprints

Formation of 10-kilobase DNA replication intermediates

Breast cancer : prognostic significance of c-erb-B2 and int-2 amplification compared with DNA ploidy, S-phase fraction, and conventional clinicopathological features

Appearance of amplified thymidylate synthase or dihydrofolate reductase genes in stage‐IV breast‐cancer patients receiving endocrine treatment

C‐ERB‐B2/INT‐2 amplification appears faster in breast‐cancer patients receiving second‐line endocrine treatment

Suchergebnisse filtern